As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
To mark Peer Review Week 2020 (September 21-25), we spoke with Dr Mario Malički, Co-Editor-in-Chief of Research Integrity and Peer Review on the importance of building trust and ensuring transparency in research and how the peer review process continues to evolve. Read the blog here.
Visit the Peer Review section edited by Dr Malički.
Announcing the launch of In Review
Research Integrity and Peer Review, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs
Aims and scope
Research Integrity and Peer Review is an international, open access, peer reviewed journal that encompasses all aspects of integrity in research publication, including peer review, study reporting, and research and publication ethics. Particular consideration is given to submissions that address current controversies and limitations in the field and offer potential solutions. We welcome research into peer review and editorial decision making, however reports of individual journal or publisher decisions or actions will not be considered.
Please click here for more information.
Research Integrity and Peer Review is endorsed by the following organizations:
The Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network works with all stakeholders, including researchers, medical journal editors, and funding bodies, to promote and support the complete and transparent reporting of all health research.
The International Society for Managing and Technical Editors (ISMTE) connects editorial office staff across all areas of academic and scholarly publishing, and work together to develop best practices, with a particular interest in publication ethics.
Joerg Meerpohl, Editor-in-Chief
Joerg Meerpohl is a board-qualified pediatrician and pediatric hematologist & oncologist. He has been working as a researcher at the German Cochrane Centre since 2007 and was appointed deputy director in 2011 and co-director in 2015. His main research interests include systematic review methodology, transparency in research and related dissemination bias as well as reporting quality in particular. Since 2015, Joerg has been a member of the Cochrane Steering Group.
For many years Joerg has also been an active member of the GRADE working group, and has run many GRADE workshops at national and international organizations. Joerg worked as a GRADE methodology advisor with several WHO panels, the European Stroke Organization and the Robert Koch Institute in Germany amongst others. In 2013 he founded the GRADE center in Freiburg, Germany and is a member of the GRADE guidance committee.
Mario Malički, Editor-in-Chief
Mario Malički has obtained his MD at the University of Zagreb School of Medicine, Croatia, MA in Literature and Medicine at King’s College, London, UK, and PhD in Medical Ethics at the University of Split School of Medicine, Split, Croatia. He has been a member of Cochrane Croatia, and of the New Frontiers of Peer Review (PEERE) EU COST Action. His main research interest is meta-science, with the focus on peer review, research integrity, authorship and transparency in reporting. His other interest includes medical ethics, hope, statistics, speculative fiction, Frank Herbert’s opus and Leonard Cohen’s poetry.
Annual Journal Metrics
80 days to first decision for reviewed manuscripts only
60 days to first decision for all manuscripts
160 days from submission to acceptance
29 days from acceptance to publication